AXGN

#1874
Axogen, Inc. Common Stock
31.7300
+2.40%
Setor:
Base:
Moeda do lucro:
Faixa diária
31.7300
31.7300
Faixa anual
17.1400
35.9999
Mudança diária
+2.40%
Mudança mensal
-8.27%
Mudança em 6 meses
+73.96%
Mudança anual
+73.96%
Fechamento anterior
30.9850
Open
31.7300
Bid
Ask
Low
31.7300
High
31.7300
Volume
118
Open full chart

Financials

Overview Relatórios Statistics Dividends
Quarterly Annual
Value 202020212022202320242025 TTM
Key stats
Valuation ratios
Profitability ratios
Liquidity ratios
Solvency ratios
Per share metrics

Axogen Inc

Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering. Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator. As of 2019, Axogen was the only commercially available allograft approved by the Food and Drug Administration for clinical use.

Notícias